These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12752522)

  • 1. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application.
    Hexsel DM; De Almeida AT; Rutowitsch M; De Castro IA; Silveira VL; Gobatto DO; Zechmeister M; Mazzuco R; Zechmeister D
    Dermatol Surg; 2003 May; 29(5):523-9; discussion 529. PubMed ID: 12752522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blind multicenter study of the efficacy and safety of injections of a commercial preparation of botulinum toxin type A reconstituted up to 15 days before injection.
    Hexsel D; Rutowitsch MS; de Castro LC; do Prado DZ; Lima MM
    Dermatol Surg; 2009 Jun; 35(6):933-9; discussion 940. PubMed ID: 19397645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Hexsel, et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application.
    Hexsel DM; Alencar de Castro I; Zechmeister D; Almeida do Amaral A
    Dermatol Surg; 2004 May; 30(5):823. PubMed ID: 15099336
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines.
    Lizarralde M; Gutiérrez SH; Venegas A
    Dermatol Surg; 2007 Nov; 33(11):1328-33; discussion 1333. PubMed ID: 17958584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
    Carruthers JA; Lowe NJ; Menter MA; Gibson J; Nordquist M; Mordaunt J; Walker P; Eadie N;
    J Am Acad Dermatol; 2002 Jun; 46(6):840-9. PubMed ID: 12063480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin A (Botox Cosmetic): a review of its use in the treatment of glabellar frown lines.
    Frampton JE; Easthope SE
    Am J Clin Dermatol; 2003; 4(10):709-25. PubMed ID: 14507232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of Skin Mechanical Properties in Patients Undergoing Botulinum Toxin Type A Injections of Forehead Rhytides.
    Min P; Zhang Z; Grassetti L; Perdanasari AT; Torresetti M; Pu Z; Zhang Y; Han S; Marsili R; Zhang YX; di Benedetto G; Lazzeri D
    Aesthetic Plast Surg; 2016 Jun; 40(3):410-20. PubMed ID: 26944891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of bacterial or fungal growth in vials of reconstituted botulinum toxin type A after storage.
    Osaki T; Osaki MH; Osaki TH; Sant'Anna AE; Yu MC; Hofling-Lima AL
    Aesthet Surg J; 2015 Feb; 35(2):189-93. PubMed ID: 25717119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines.
    Carruthers JD; Lowe NJ; Menter MA; Gibson J; Eadie N;
    Plast Reconstr Surg; 2003 Sep; 112(4):1089-98. PubMed ID: 12973229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botox: shaken, not stirred.
    Kazim NA; Black EH
    Ophthalmic Plast Reconstr Surg; 2008; 24(1):10-2. PubMed ID: 18209633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
    Alster TS; Lupton JR
    Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of reconstituted and stored botulinum toxin type A: an electrophysiologic and visual study in the auricular muscle of the rabbit.
    Jabor MA; Kaushik R; Shayani P; Ruiz-Razura A; Smith BK; Morimoto KW; Cohen BE
    Plast Reconstr Surg; 2003 Jun; 111(7):2419-26; discussion 2427-31. PubMed ID: 12794491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eyebrow height after botulinum toxin type A to the glabella.
    Carruthers A; Carruthers J
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S26-31. PubMed ID: 17241411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinkles.
    Sadick NS
    Dermatol Surg; 2003 May; 29(5):501-7; discussion 507. PubMed ID: 12752518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines.
    Carruthers A; Carruthers J; Flynn TC; Leong MS
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S60-8. PubMed ID: 17241416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a novel botulinum toxin type A product for the treatment of moderate to severe glabellar lines: a randomized, double-blind, active-controlled multicenter study.
    Won CH; Lee HM; Lee WS; Kang H; Kim BJ; Kim WS; Lee JH; Lee DH; Huh CH
    Dermatol Surg; 2013 Jan; 39(1 Pt 2):171-8. PubMed ID: 23301821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type B for glabellar wrinkles: a prospective open-label response study.
    Sadick NS; Faacs
    Dermatol Surg; 2002 Sep; 28(9):817-21. PubMed ID: 12269875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.